Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.350
+0.030 (2.27%)
At close: May 12, 2025, 4:00 PM
1.400
+0.050 (3.70%)
After-hours: May 12, 2025, 5:23 PM EDT
Autolus Therapeutics Employees
As of December 31, 2024, Autolus Therapeutics had 650 total employees, including 647 full-time and 3 part-time employees. The number of employees increased by 179 or 38.00% compared to the previous year.
Employees
650
Change (1Y)
179
Growth (1Y)
38.00%
Revenue / Employee
$13,863
Profits / Employee
-$366,358
Market Cap
359.27M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AUTL News
- 1 day ago - Autolus Therapeutics plc (AUTL) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Autolus Therapeutics Reports First Quarter 2025 Financial Results and Business Updates - GlobeNewsWire
- 17 days ago - Autolus Therapeutics Announces License of AUCATZYL® (obecabtagene autoleucel) Issued by UK MHRA for Adult Patients (≥ 18 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)(1) - GlobeNewsWire
- 19 days ago - Autolus Therapeutics Highlights Advancing Autoimmune Pipeline at R&D Investor Event - GlobeNewsWire
- 20 days ago - Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 - GlobeNewsWire
- 5 weeks ago - Autolus Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Autolus Therapeutics to Host R&D Investor Event on Wednesday, April 23, 2025 - GlobeNewsWire
- 7 weeks ago - Autolus Therapeutics plc (AUTL) Q4 2024 Earnings Conference Call Transcript - Seeking Alpha